Evidence map›Paper›PMID 36230653›Full record

ArticleCancers2022

Prognostic Ability of Tumor Budding Outperforms Poorly Differentiated Clusters in Gastric Cancer.

Luca Szalai, Ákos Jakab, Ildikó Kocsmár, Ildikó Szirtes, István Kenessey, Attila Szijártó, Zsuzsa Schaff, András Kiss, Gábor Lotz, Éva Kocsmár

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Predictive value of tumor budding in head and neck squamous cell carcinoma: an update.Virchows Archiv : an international journal of pathology · 2023
    Review
  13. Tumor budding in gastric cancer.World journal of gastrointestinal surgery · 2023
    Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Luca SzalaiDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői Str. 93, H-1091 Budapest, Hungary.
Ákos JakabDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői Str. 93, H-1091 Budapest, Hungary.
Ildikó KocsmárDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői Str. 93, H-1091 Budapest, Hungary.
Ildikó SzirtesDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői Str. 93, H-1091 Budapest, Hungary.
István KenesseyDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői Str. 93, H-1091 Budapest, Hungary.ORCID 0000-0002-6963-8489
Attila SzijártóDepartment of Surgery, Transplantation and Gastroenterology, Semmelweis University, Üllői Str. 78, H-1091 Budapest, Hungary.
Zsuzsa SchaffDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői Str. 93, H-1091 Budapest, Hungary.
András KissDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői Str. 93, H-1091 Budapest, Hungary.ORCID 0000-0002-7453-3163
Gábor LotzDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői Str. 93, H-1091 Budapest, Hungary.ORCID 0000-0002-6921-8978
Éva KocsmárDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői Str. 93, H-1091 Budapest, Hungary.ORCID 0000-0003-3061-1323
Semmelweis University · HU

Funding

Ministry for Innovation and Technology 2020-4.1.1.-TKP2020Ministry for Innovation and Technology ÚNKP-20-3-II-SE-36Ministry for Innovation and Technology ÚNKP-21-4-I-SE-32Ministry of Human Capacities EFOP-3.6.3-VEKOP-16-2017-00009National Research, Development and Innovation Office (Hungary) K_18 128881National Research, Development and Innovation Office (Hungary) K_22 142604Semmelweis University Start-up grant for G. Lotz
6 · The paper itself

Abstract

The prognostic value of histological phenomena tumor budding (TB) and poorly differentiated clusters (PDCs) have been less studied in gastric cancer (GAC) and the data provided so far are controversial. In our study, 290 surgically resected GAC cases were evaluated for TB according to the criteria of International Tumor Budding Consensus Conference (ITBCC) and PDC, and both parameters were scored on a three-grade scale as described for colorectal cancer previously (0: Grade0, 1-4: Grade1, 5-9: Grade2 and ≥10: Grade3) and classified as low (Grade0-2) and high (Grade3) TB/PDC. High TB/PDC was associated with diffuse-type morphology, higher pT status, incomplete surgical resection, poor tumor differentiation and perineural and lymphovascular invasion. Multivariable survival analyses have shown an independent prognostic role of high TB with poorer overall survival in the total cohort (

Indexed as

gastric cancerlymph node metastasispoorly differentiated clustersurvivaltumor budding

Identifiers

PMID36230653
PMCPMC9563769
OpenAlexW4297464548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.